Please login to the form below

COVID-19 testing

This page shows the latest COVID-19 testing news and features for those working in and with pharma, biotech and healthcare.

Sanofi, GSK to launch human trials of COVID-19 vaccine

Sanofi and GSK bring proven science and technology to the fight against the global COVID-19 pandemic, with the shared objective of delivering a safe and effective vaccine. ... The deal ensures early access to the COVID-19 vaccine if it proves effective

Latest news

Roche plans to launch rapid COVID-19 antigen test later this month

As the COVID-19 pandemic persists, healthcare systems remain challenged. Testing continues to be an important focus for many countries. ... COVID-19 testing solutions that provide healthcare professionals and patients with a quick answer regarding their
EU concludes discussions with Moderna for COVID-19 vaccine

doses once the vaccine has proven to be safe and effective against COVID-19. ... Last week, AstraZeneca finalised an agreement with the EC to provide 400 million doses of its potential COVID-19 vaccine once it completes clinical testing and wins
Britain ramps up COVID-19 testing to track spread of infections

The expanded study will provide extensive, weekly data on the spread of the coronavirus across the nation, and will support rapid testing and diagnosis of COVID-19. ... The government is also providing a £2m grant to the ZOE COVID-19 Symptom Study app
Russia becomes first country to approve a COVID-19 vaccine

Vaccine approved after less than two months of human testing. Russia has become the first country in the world to grant regulatory approval to a COVID-19 vaccine, ‘Sputnik V’. ... By comparison, Moderna began testing its COVID-19 vaccine candidate
UK will provide millions of 90-minute COVID-19 tests over the coming months

The two new tests are able to detect the SARS-CoV-2 virus, which causes COVID-19, within 90 minutes. ... LamPORE has the potential to deliver a highly effective and, crucially, accessible global testing solution, not only for COVID-19 but also for a

More from news
Approximately 1 fully matching, plus 14 partially matching documents found.

Latest Intelligence

The power of remote personal interactions: COVID-19 pandemic and the increasing role of remote engagement

when/the extent to which countries were most significantly impacted by COVID-19. ... Although some level of face-to-face interaction is returning, this interaction:. is likely to come with additional requirements for company representatives for COVID-19
As COVID-19 takes over the world, biopharma fights back

Encouraged by this initial data, Sanofi and Rengeneron decided to take their own IL-6 inhibitor, Kevzara (sarilumab), into clinical testing for COVID-19. ... patients with COVID-19, as appropriate, when a clinical trial is not available or feasible”.

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

Social listening report: Is COVID-19 impacting clinical trial recruitment?

Outside of COVID-19 research, clinical trials are being impacted regardless of indication. ... COVID-19 testing is not part of trial protocols and patients may need to be removed from study populations for safety reasons.

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company

Say Communications

Influencing positive behaviours and delivering change is what drives us, using thought leadership, education, social and professional engagement and compelling,...

Latest intelligence

Surviving cancer: a new era for patients: Now more than ever, a shift in perspective is needed...
Crisis? No problem!: Issues planning & management for pharma spokespeople, by Andrew Smith...
Are patient recruitment and retention rates rising or falling?: First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....